We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App





Vedalab Presents Wide Range of Quantitative Rapid Tests

By LabMedica International staff writers
Posted on 13 Nov 2023

Vedalab (Cerisé, France) is presenting its wide range of lateral flow qualitative rapid tests and rapid tests for home use alongside its new generation rapid test reader at MEDICA 2023. More...

Vedalab offers several rapid tests for drugs of abuse detection (one drug/test) for home use including cannabinoid, cocaine, opiates, amphetamines and methamphetamines. These tests are to be used with urine samples. Vedalab also offers an immunochromatographic rapid test for the qualitative detection of respiratory syncytial virus (RSV) and influenza A and B viruses in nasal or nasopharyngeal swab samples. This is in addition to its immunochromatographic rapid test for the quantitative detection of anti-spike (S1) IgM and IgG antibodies to SARS-CoV-2 virus in human whole blood, plasma, or serum samples. When used in combination with the VEDALAB Easy reader+ instrument, it can detect and quantify IgM and IgG antibodies to the spike SARS-CoV-2 protein produced after virus infection in human serum, plasma, or finger prick whole blood samples.

At MEDICA 2023, Vedalab is demonstrating the Easy reader+ POC reader that allows quantitative measurements from fingerprick whole blood samples using rapid lateral flow tests. The instrument includes the most advanced and up-to-date technologies (touch screen, enhanced memory, and internet upgrading). The quantitative lateral flow immunochromatography analyzer is intended to provide a quantitative immunochromatography assay result for a wide range of otherwise purely qualitative rapid test devices to increase the accuracy and efficiency of the home, point of care, and laboratory testing of the relevant marker analytes.

Related Links:
Vedalab 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: For decades, laboratories have adjusted total calcium for albumin, but growing evidence shows these corrections often perform poorly and may cause harm (image credit: iStock)

International Experts Recommend Ending Routine 'Corrected' Calcium Reporting

Interpreting serum calcium can be clinically challenging when albumin levels vary, especially in patients with chronic illness or kidney disease. For decades, laboratories have used formulas to adjust... Read more

Microbiology

view channel
Image: A member of the WHO Ebola ring vaccination team vaccinates a man in Bosolo village during a 2018 Ebola outbreak in Congo (Photo courtesy of WHO/Lindsay Mackenzie)

Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo

In eastern Democratic Republic of the Congo, communities are confronting a resurgence of Bundibugyo ebolavirus, a rarer species for which no vaccines or treatments have been approved. Ebola is a highly... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.